Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Igor Resnick(Hebrew University of Jerusalem), Reuven Or(Hebrew University of Jerusalem), Polina Stepensky, Avichai Shimoni, Claudine Barkats, Amos Toren, Arnon Nagler(Tel Aviv University), Nira Varda‐Bloom, Lyudmila Rheingold, Bella Bielorai, Moshe Yeshurun, Michael Y. Shapira(Hebrew University of Jerusalem), Allan I. Bloom, David Mankuta(Hadassah Academic College), Tsila Zuckerman(Johannes Gutenberg University Mainz)

PubMed

January 1, 2013

Cited by 118

Related Papers

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.9k

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.8k

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

|New England Journal of Medicine|2020|859

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

|Journal of Clinical Oncology|2013|439

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

|Blood|2010|430